Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
about
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics.Fibrosis: Lessons from OMICS analyses of the human lung.Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosisLocalized hypoxia links ER stress to lung fibrosis through induction of C/EBP homologous protein
P2860
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
@en
type
label
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
@en
prefLabel
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
@en
P2093
P2860
P356
P1476
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
@en
P2093
Ana L Mora
Annie Pardo
Mauricio Rojas
Moises Selman
P2860
P2888
P304
P356
10.1038/NRD.2017.170
P577
2017-10-06T00:00:00Z
P6179
1092113557